Cargando…
Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions
The tumor microenvironment (TME) is a critical regulator of tumor growth, progression, and metastasis. Since immune cells represent a large fraction of the TME, they play a key role in mediating pro- and anti-tumor immune responses. Immune escape, which suppresses anti-tumor immunity, enables tumor...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706102/ https://www.ncbi.nlm.nih.gov/pubmed/34948104 http://dx.doi.org/10.3390/ijms222413311 |
_version_ | 1784622111013208064 |
---|---|
author | Pansy, Katrin Uhl, Barbara Krstic, Jelena Szmyra, Marta Fechter, Karoline Santiso, Ana Thüminger, Lea Greinix, Hildegard Kargl, Julia Prochazka, Katharina Feichtinger, Julia Deutsch, Alexander JA. |
author_facet | Pansy, Katrin Uhl, Barbara Krstic, Jelena Szmyra, Marta Fechter, Karoline Santiso, Ana Thüminger, Lea Greinix, Hildegard Kargl, Julia Prochazka, Katharina Feichtinger, Julia Deutsch, Alexander JA. |
author_sort | Pansy, Katrin |
collection | PubMed |
description | The tumor microenvironment (TME) is a critical regulator of tumor growth, progression, and metastasis. Since immune cells represent a large fraction of the TME, they play a key role in mediating pro- and anti-tumor immune responses. Immune escape, which suppresses anti-tumor immunity, enables tumor cells to maintain their proliferation and growth. Numerous mechanisms, which have been intensively studied in recent years, are involved in this process and based on these findings, novel immunotherapies have been successfully developed. Here, we review the composition of the TME and the mechanisms by which immune evasive processes are regulated. In detail, we describe membrane-bound and soluble factors, their regulation, and their impact on immune cell activation in the TME. Furthermore, we give an overview of the tumor/antigen presentation and how it is influenced under malignant conditions. Finally, we summarize novel TME-targeting agents, which are already in clinical trials for different tumor entities. |
format | Online Article Text |
id | pubmed-8706102 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87061022021-12-25 Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions Pansy, Katrin Uhl, Barbara Krstic, Jelena Szmyra, Marta Fechter, Karoline Santiso, Ana Thüminger, Lea Greinix, Hildegard Kargl, Julia Prochazka, Katharina Feichtinger, Julia Deutsch, Alexander JA. Int J Mol Sci Review The tumor microenvironment (TME) is a critical regulator of tumor growth, progression, and metastasis. Since immune cells represent a large fraction of the TME, they play a key role in mediating pro- and anti-tumor immune responses. Immune escape, which suppresses anti-tumor immunity, enables tumor cells to maintain their proliferation and growth. Numerous mechanisms, which have been intensively studied in recent years, are involved in this process and based on these findings, novel immunotherapies have been successfully developed. Here, we review the composition of the TME and the mechanisms by which immune evasive processes are regulated. In detail, we describe membrane-bound and soluble factors, their regulation, and their impact on immune cell activation in the TME. Furthermore, we give an overview of the tumor/antigen presentation and how it is influenced under malignant conditions. Finally, we summarize novel TME-targeting agents, which are already in clinical trials for different tumor entities. MDPI 2021-12-10 /pmc/articles/PMC8706102/ /pubmed/34948104 http://dx.doi.org/10.3390/ijms222413311 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Pansy, Katrin Uhl, Barbara Krstic, Jelena Szmyra, Marta Fechter, Karoline Santiso, Ana Thüminger, Lea Greinix, Hildegard Kargl, Julia Prochazka, Katharina Feichtinger, Julia Deutsch, Alexander JA. Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions |
title | Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions |
title_full | Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions |
title_fullStr | Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions |
title_full_unstemmed | Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions |
title_short | Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions |
title_sort | immune regulatory processes of the tumor microenvironment under malignant conditions |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706102/ https://www.ncbi.nlm.nih.gov/pubmed/34948104 http://dx.doi.org/10.3390/ijms222413311 |
work_keys_str_mv | AT pansykatrin immuneregulatoryprocessesofthetumormicroenvironmentundermalignantconditions AT uhlbarbara immuneregulatoryprocessesofthetumormicroenvironmentundermalignantconditions AT krsticjelena immuneregulatoryprocessesofthetumormicroenvironmentundermalignantconditions AT szmyramarta immuneregulatoryprocessesofthetumormicroenvironmentundermalignantconditions AT fechterkaroline immuneregulatoryprocessesofthetumormicroenvironmentundermalignantconditions AT santisoana immuneregulatoryprocessesofthetumormicroenvironmentundermalignantconditions AT thumingerlea immuneregulatoryprocessesofthetumormicroenvironmentundermalignantconditions AT greinixhildegard immuneregulatoryprocessesofthetumormicroenvironmentundermalignantconditions AT kargljulia immuneregulatoryprocessesofthetumormicroenvironmentundermalignantconditions AT prochazkakatharina immuneregulatoryprocessesofthetumormicroenvironmentundermalignantconditions AT feichtingerjulia immuneregulatoryprocessesofthetumormicroenvironmentundermalignantconditions AT deutschalexanderja immuneregulatoryprocessesofthetumormicroenvironmentundermalignantconditions |